Induction of leydig cell tumors by lacidipine via up-regulation of the LHRH receptor on leydig cells in rats

Journal of Toxicological Sciences

Volumn 23, Issue 1, 1998, Pages 35-52

  Hamada, Yoshimasa ^a   Futamura, Yoshihiro ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Lacidipine; Leydig cell tumors; Luteinizing hormone releasing hormone receptor; Protein kinase C; Rats; Testosterone

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; GONADORELIN RECEPTOR; LACIDIPINE; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; NICARDIPINE; PROTEIN KINASE C; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HORMONE DETERMINATION; LEYDIG CELL TUMOR; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MONKEY; MOUSE; NONHUMAN; RAT; SPECIES DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ANIMALIA;

EID: 0031913857     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.23.35     Document Type: Article

References (40)

1. Bertoft, E., Mäntausta, O., Sundqvist, C. and Lukola, A. (1987): Comparison between radioimmunoassay and a new time-resolved fluoroimmunoassay: Determination of total serum testosterone in male mink (Mustela vison). Anim. Reprod. Sci., 12, 291-295.
2. Boorman, G. A., Hamlin, M. H. II and Eustis, S. L. (1987): Focal interstitial cell hyperplasia, testes, rat. In Genital System, Monographs on Pathology of Laboratory Animals (Lones, T. C., Mohr, U., and Hunt, R. D., eds.) pp. 200-204, Springer-Verlag, Berlin.
3. Campana, D., Coustan-Smith, E. and Janossy, G. (1988): Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells. J. Immunol. Methods, 107, 79-88.
4. Centol, I., Deniz, A., Benitez, L., Marrero, I., Fanjul, L. F. and Ruiz de Galarreta, C. M. (1988): Functional activity of rat testicular cells in culture. Biochem. Int., 16, 311-322.
5. Christensen, A. K. and Peacock, K. C. (1980): Increase in Leydig cell number in testes of adult rats treated chronically with an excess of human chorionic gonadotropin. Biol. Reprod. 22, 383-391.
6. Clayton, R. N. and Huhtaniemi, I. T. (1982): Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature. 299, 56-59.
7. Creasy, D. M. and Foster, P. M. D. (1991): Male Reproductive System. In Handbook of Toxicologic Pathology (Haschek, W. M. and Rousseaux, C. G., eds.). pp 829-887, Academic Press, Inc, San Diego.
8. Davis, J. S. (1994): Mechanism of hormone action: luteinizing hormone receptors and second-messenger pathway. Curr. Opin. Obstet. Gynecol., 6, 254-261.
9. Dehejia, A., Nozu, K., Catt, K. L. and Dufau, M. L. (1982): Luteinizing hormone receptors and gonadotropic activation of purified rat Leydig cells. J. Biol. Chem., 257, 13781-13882.
10. Fitzgerald, J. E., Sanyer, J. L., Schardein, J. L., Lake, R. S., McGuire, E. J. and de la Iglesia, F. A. (1981): Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil. J. Natl. Cancer Inst., 67, 1105-1116.
11. Fort, F. L., Miyajima, H., Ando, T., Suzuki, T., Yamamoto, M., Hamashima, T., Sato, S., Kitazaki, T., Mahony, M. C. and Hodgen, G. D. (1995): Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole. Fundam, Appl. Toxicol., 26, 191-202.
12. Fox, S. R. and Smith M. S. (1984): The suppression of pulsatile luteinizing hormone secretion during lactation in the rat. Endocrinology, 115, 2045-2051.
13. Georgellis, A. and Rydström, J. (1989): Cell-specific metabolic activation of 7, 12-dimethylbenz[a] anthracene in rat testis. Chem. -Biol. Interactions, 72, 65-78.
14. Goerttler, K., Edler, L. and Loehrke, H. (1992): Long term tumorigenicity of a single application of indomethacin or Amuno in adolescent and in adult male Sprague-Dawley rats. Exp. Toxic. Pathol., 44, 361-370.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
16. Hirai, S., Izumi, Y., Higa, K., Kaibuchi, K., Mizuno, K., Osada, S., Suzuki, K. and Ohno, S. (1994): Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKCδ. EMBO J., 13, 2331-2340.
17. Hukkelhoven, M. W. A. C., Vromans, E., Markslag, A. M. G. and Vermorken, A. J. M. (1981): A simple fluorimetric microassay for DNA in hair follicles or fractions of hair follicles. Anticancer Res., 1, 341-344.
18. Hunter, M. G., Sullivan, M. H. F., Dix, C. J., Aldred, L. F. and Cooke, B. A. (1982): Stimulation and inhibition by LHRH analogues of cultured rat Leydig cell function and lack of effect on mouse Leydig cells. Mol. Cell. Endocrinol., 27, 31-44.
19. Ishihara, S., Mastui, K., Morima, H., Mishima, C., Honda, M., Tomonobe, M., Kanao, H., Fushimi, N. and Kasajima Y. (1988): Solid phase radioimmunoassay of testosterone. J. Med. Pharm. Sci., 20, 1111-1117.
20. Itabashi, M., Numata, K., Urata, K., Tsubota, M. and Nemoto, N. (1991): Fundamental evaluation of rat TSH, LH, FSH, PRL, and GH assay systems from Amersham International pic. J. Med. Pharm. Sci., 26, 807-817.
21. Jacobs, B. B. and Huseby, R. A. (1967): Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol. Appl. Pharmacol., 48, 237-248.
22. Kramer, C. Y. (1956): Extension of multiple range tests to group means with unequal number of replications. Biometrics, 12, 307-310.
23. Leslie, G. B., Noakes, D. N., Pollitt, F. D., Roe, F. J. C. and Walker, T. F. (1981): A two-year study with cimetidine in the rat: Assessment for chronic toxicity and carcinogenicity. Toxicol. Appl. Pharmacol., 61, 119-137.
24. Liu, T. C. and Jackson, G. L. (1981): Independent action of gonadotropin-releasing hormone upon cyclic GMP production and leutinizing hormone release. Am. J. Physiol., 241, E6-E13.
25. Lundin, A., Rickardsson, A. and Thore, A. (1976): Continuous monitoring of ATP-converting reactions by purified firefly luciferase. Anal. Biochem., 75, 611-620.
26. Maekawa, A., Kurokawa, Y., Takahashi, M., Kokubo, T., Ogiu, T., Onodera, H., Tanigawa, H., Ohono, Y., Furukawa, F. and Hayashi, Y. (1983): Spontaneous tumors in F-344/Du Crj rats. Gann, 74, 365-372.
27. Majercik, M. H., Czerwiec, F. S. and Puett, D. (1989): Effects of hormones and intracellular mediators on differentiated functions of cultured Leydig tumor cells. Steroids, 54, 627-645.
28. Micheli, D., Collodel, A., Semeraro, C., Gaviraghi, G. and Carpi, C. (1990): Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. J. Cardiovasc. Pharmacol., 15, 666-675.
29. Micheli, D., Massagrande, M., Giacometti, A., Collodel, A. and Gaviraghi, G. (1992): A comparative study on the vascular selectivity of lacidipine in the pithed rat. Pharmacology, 44, 150-157.
30. Moul, J. W., Theune, S. M. and Chang, E. H. (1992): Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization. Genes, Chromosomes & Cancer, 5, 109-118.
31. 2+ and protein kinase C. Eur. J. Endocrinol., 136, 123-127.
32. Nozu, K., Dehejia, A., Zawistowich, L., Catt, K. J. and Dufau, M. L. (1981): Gonadotropin-induced receptor regulation and steroidogenic lesions in cultured Leydig cells. J. Biol. Chem., 256, 12875-12882.
33. Roberts, S. A., Nett, T. M., Hartman, H. A., Adams, T. E. and Stoll, R. E. (1989): SDZ 200-110 induces Leydig cell tumors by increasing gonadotropins in rats. J. Am. Coll. Toxicol. 8, 487-505.
34. Rustla, M. and Shublk, P. (1979): Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC(WI)BR rats. J. Natl. Cancer Inst. 63, 863-868.
35. 2+ in steroidogenesis in Leydig cells. Biochem. J., 236, 45-51.
36. Tukey, J. W. (1949): Comparing individual means in the analysis of variance. Biometrics, 5, 99-114.
37. Uemura, T., Nakamura, Y., Okamiya, Y., Asukai, K., Kimura, A., Taga, M. and Mizuguchi, K. (1988): Determination of blood PRL by time resolved fluoroimmunoassay. A study of the Delfia Prolactin Kit. World Obestet. Gynecol., 40, 1081-1088.
38. Wada, H., Ota, T., Fujimura, T., Kimura, H., Ariga, F., Koike, T., Watanabe, Y., Suzuki, R., Neda, K. and Nakamori, K. (1993): A 52-week oral toxicity study of flutamide in male rats followed by recovery test. Pharmacometrics, 45, 141-162.
39. Whitehead, T. P., Thorpe, G. H. G., Carter, T. J. N., Groucutt, C. and Kricka, L. J. (1983): Enhanced luminescence procedure for sensitive determination of peroxidase-labelled conjugates in immunoassay. Nature, 305, 158-159.
40. Yano, T., Taura, C., Shibata, M., Hirono, Y., Ando, S., Kusubata, M., Takahashi, T. and Inagaki, M. (1991): A monoclonal antibody to the phosphorylated form of glial fibrillary acidic protein: Application to a non-radioactive method for measuring protein kinase activities. Biochem. Biophys. Res. Comm., 175, 1144-1151.